Reasons for Vaccine AstraZeneca and J&J in Europe Only for the Elderly

Jakarta, CNN Indonesia –

The government decided to stop using it AstraZeneca vaccine, particularly in the production (batch) CTMAV547. This policy emerged after a Jakarta resident died of Trio Fauqi Virdaus (22) after receiving the vaccine Covid-19 that.

The government has not yet issued a conclusion regarding the incident. The government claims that it is conducting a thorough investigation to find out exactly what caused Trio’s death.

In some countries, the AstraZeneca vaccine is not intended for people under 50 years of age. As in Australia for example who prescribes the vaccine can only be given to citizens over 50 years.

Countries like Italy and France have also decided on the AstraZeneca vaccine for people over 55. In fact, Belgium decided not to use the vaccine.

Launch ABC News, a factor that has led some countries to give the AstraZeneca vaccine to people over 50 years of age, associated with a rare new disease in the form of blood clots.

The risk of blood clots has actually been linked to vaccines by some medical authorities, but that risk in individual cases is very small. A rare new disease that causes fear is named Thrombosis with Thrombocytopenia Syndrome or TTS.

TTS is when a person develops a blood clot in which the number of platelets in their blood drops. Currently, the condition is seen in a minority of people who received the AstraZeneca vaccine in Europe and one person in Australia is also suspected of developing TTS after receiving the injection.

Research shows TTS affects four to six people per one million vaccinations, or somewhere in the world one in every 200,000 people.

Experts say around 25 percent of people who develop TTS die, which means at current rates, roughly one person per 800,000 given the AstraZeneca vaccine is thought to have died from TTS.

Australian medical authorities say the rare syndrome is most likely a form of an immune response, so it is likely that the disease affects young people with “strong” immune systems.